Cases 1 - 6 of 6
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01445
Plaintiff:
Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. and Chen Hsing Hsu
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Lupin Ltd.
as 1:2019cv00884
Plaintiff:
Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu and Panion & BF Biotech, Inc.
Defendant:
Lupin Ltd.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00040
Plaintiff:
Chen Hsing Hsu, Panion & BF Biotech, Inc. and Keryx Biopharmaceuticals, Inc
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Chemo Research S.L. et al
as 1:2019cv00220
Plaintiff:
Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu and Panion & BF Biotech, Inc.
Defendant:
Chemo Research S.L. and Insud Pharma S.L.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Lupin Ltd. et al
as 1:2018cv01968
Plaintiff:
Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu and Panion & BF Biotech, Inc.
Defendant:
Lupin Ltd. and Lupin Atlantis Holdings SA
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
